Celularity Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Celularity Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue54.2222.7717.9821.3414.28
Cost of Revenue14.9916.0219.679.654.93
Gross Profit39.236.76-1.6911.689.35
Operating Expenses
Research & Development17.3930.4778.3688.3552.71
Selling, General & Administrative58.6450.5866.0271.3431.34
Operating Expenses77.7883.23146.58161.8987.44
Operating Income-38.55-76.48-148.27-150.20-78.09
Other Income/Expense
Interest Income0.330.320.370.330.37
Interest Expense-6.263.020.003.17-2.35
Other Income/Expense-9.20-117.11162.1152.95-54.59
Income
Income Before Tax-57.89-196.2914.21-100.10-212.93
Income Tax Expense0.000.010.010.02-4.70
Net Income-57.89-196.3014.19-100.12-208.23
Net Income - Continuous Operations-57.89-196.3014.19-100.120.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-30.63-183.9523.64-88.11-69.92
EBIT-38.55-193.2714.21-96.93-78.09
Depreciation & Amortization7.922.192.192.198.17
Earnings Per Share
Basic EPS-3.00-11.001.00-15.00-113.00
Diluted EPS-3.00-11.001.00-15.00-113.00
Basic Shares Outstanding21.8917.8113.996.711.84
Diluted Shares Outstanding21.8917.8114.986.711.84